Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrus Chargari

Showing results (271-280 of 379) with videos related to

Pageof 38
Sort By:
World Journal of Urology|June 7, 2025
Tailoring prostate cancer external beam radiotherapy for patients with lower urinary tract symptomsJennifer Le Guévelou, Romain Mathieu, Arthur Peyrottes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2018
Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancerLars Fokdal, Richard Pötter, Kathrin Kirchheiner, et al.
Brachytherapy|August 1, 2018
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancerPierre Annede, Hugues Mailleux, Patrick Sfumato, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2017
Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs)Eleonor Rivin Del Campo, Sofia Rivera, María Martínez-Paredes, et al.
Clinical and Translational Radiation Oncology|August 4, 2018
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapyAntoine Schernberg, Pierre Blanchard, Cyrus Chargari, et al.
Oncoimmunology|May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapyRomain-David Seban, Charlotte Robert, Laurent Dercle, et al.
Brachytherapy|July 27, 2017
Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinomaWarren Bacorro, Alexandre Escande, Stéphane Temam, et al.
Molecular Cancer Therapeutics|May 4, 2013
IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapyCharles Ferté, Yohann Loriot, Céline Clémenson, et al.
Anti-Cancer Drugs|April 2, 2013
First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma: data on safety and efficacyCyrus Chargari, Cécile Pacaut, Sylvestre Le Moulec, et al.
Brachytherapy|February 11, 2018
Image-guided adaptive brachytherapy in primary vaginal cancers: A monocentric experienceAndres Huertas, Isabelle Dumas, Alexandre Escande, et al.
Pageof 38

Showing results (271-280 of 379) with videos related to

Sort By:
Pageof 38
World Journal of Urology|June 7, 2025
Tailoring prostate cancer external beam radiotherapy for patients with lower urinary tract symptomsJennifer Le Guévelou, Romain Mathieu, Arthur Peyrottes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2018
Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancerLars Fokdal, Richard Pötter, Kathrin Kirchheiner, et al.
Brachytherapy|August 1, 2018
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancerPierre Annede, Hugues Mailleux, Patrick Sfumato, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2017
Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs)Eleonor Rivin Del Campo, Sofia Rivera, María Martínez-Paredes, et al.
Clinical and Translational Radiation Oncology|August 4, 2018
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapyAntoine Schernberg, Pierre Blanchard, Cyrus Chargari, et al.
Oncoimmunology|May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapyRomain-David Seban, Charlotte Robert, Laurent Dercle, et al.
Brachytherapy|July 27, 2017
Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinomaWarren Bacorro, Alexandre Escande, Stéphane Temam, et al.
Molecular Cancer Therapeutics|May 4, 2013
IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapyCharles Ferté, Yohann Loriot, Céline Clémenson, et al.
Anti-Cancer Drugs|April 2, 2013
First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma: data on safety and efficacyCyrus Chargari, Cécile Pacaut, Sylvestre Le Moulec, et al.
Brachytherapy|February 11, 2018
Image-guided adaptive brachytherapy in primary vaginal cancers: A monocentric experienceAndres Huertas, Isabelle Dumas, Alexandre Escande, et al.
Pageof 38